ZLAB Stock Summary and Trading Ideas (Zai Lab Limited - American Depositary Shares | NASDAQ:ZLAB)

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.

Zai Lab Limited - American Depositary Shares trades on the NASDAQ stock market under the symbol ZLAB.

As of May 13, 2024, ZLAB stock price climbed to $21.52 with 627,389 million shares trading.

ZLAB has a beta of 1.82, meaning it tends to be more sensitive to market movements. ZLAB has a correlation of 0.13 to the broad based SPY ETF.

ZLAB has a market cap of $2.12 billion. This is considered a Mid Cap stock.

Last quarter Zai Lab Limited - American Depositary Shares reported $87 million in Revenue and -$.55 earnings per share. This beat revenue expectation by $12 million and exceeded earnings estimates by $.37.

In the last 3 years, ZLAB stock traded as high as $181.92 and as low as $13.48.

The top ETF exchange traded funds that ZLAB belongs to (by Net Assets): IBB, SBIO, PGJ, GERM, FMED.

ZLAB stock has underperformed the market in the last year with a return of -42.6%, while SPY returned +27.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ZLAB shares. However, ZLAB has outperformed the market in the last 3 month and 2 week periods, returning +15.2% and +35.3%, while SPY returned +4.3% and +2.5%, respectively. This indicates ZLAB has been having a stronger performance recently.

ZLAB support price is $19.31 and resistance is $20.85 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ZLAB stock will trade within this expected range on the day.